The Cancer Stage Shifting Initiative: Registry and Biorepository to Research and Address Health Disparities in Cancer Care

Recruiting now

Conditions studied: Cancer, Cancer Comorbidities

In brief

The goal of this observational study is to establish a patient registry and a biorepository (sample collection and storage) to investigate health disparities, access, and barriers to cancer screening and early detection technologies. The registry and biorepository will serve as a resource to support Cancer Early Detection (CED) screenings and future research focused on communities at increased risk for cancer. The study seeks to address: •Barriers and disparities in cancer prevention, screening, and treatment, particularly in historically underrepresented populations. Participants will: * Attend a minimum of five clinic visits over a five-year period for scheduled annual assessments while actively enrolled in the study. * Complete questionnaires at each visit that collect information on their medical history, cancer history, and family cancer history. * Allow relevant health information from their electronic health records (EHR) to be collected and reviewed. * Provide blood, saliva, and stool samples for research purposes. * Enter a long-term follow-up period for an additional five years.

Key facts

Study ID

NCT07461493

Run by

National Minority Quality Forum

People needed

100000

Starts

2025-03-11

Expected to finish

2039-03-01

Last updated by the study team

2026-04-08

Who can join

Age: 35 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Adults 35 years and older.
• Participant provides written informed consent prior to initiation of any study procedures.
• Participant understands the purpose and procedures of the study.
• Participant agrees that demographic data, medical history, and social determinants of health on the enrollment questionnaires can be used for research purposes.
• Participant agrees to the release and review of their electronic medical record.
• Participant agrees to be followed for the duration outlined in this protocol.
• Biorepository
• Participant is able, in the investigator's professional opinion, to provide up to 100 mLs of whole blood at the Screening Visit and at the Interim Visits.
• Participant is a healthy, nonpregnant adult.
• Participant weighs at least 110 pounds.
• Participant has negative viral test results.

You may not qualify if…

• Registry
• Any medical or mental condition that would interfere with the subjects' ability to willingly give written informed consent.
• Participants who are unable to understand the study protocol or unable to give informed consent.
• Participants under the age of 35 at the time of enrollment.
• Biorepository
• Women of childbearing age that think they may be pregnant or are planning to get pregnant within the study timeframe.
• Participants who weigh under 110 pounds.
• Participants who, in the opinion of the investigator, are unable to provide biospecimen samples.

Where it is running

• Life in 3D Health Services — Flint, Michigan, United States (enrolling)
• Grace Clinic — Houston, Texas, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.